Evidence map›Paper›PMID 29095570›Full record

ArticleThe FEBS journal2018

Mechanisms of proton relay and product release by Class A β-lactamase at ultrahigh resolution.

Eric M Lewandowski, Kathryn G Lethbridge, Ruslan Sanishvili, Joanna Skiba, Konrad Kowalski, Yu Chen

Open access · bronzeAbstract read
In one paragraph

Article in The FEBS journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Mechanism of proton transfer in class A β-lactamase catalysis and inhibition by avibactam.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Eric M LewandowskiDepartment of Molecular Medicine, University of South Florida College of Medicine, Tampa, FL, USA.
Kathryn G LethbridgeDepartment of Molecular Medicine, University of South Florida College of Medicine, Tampa, FL, USA.
Ruslan SanishviliGMCA@APS, X-ray Science Division, Advanced Photon Source, Argonne National Laboratory, IL, USA.
Joanna SkibaDepartment of Organic Chemistry, Faculty of Chemistry, University of Lodz, Poland.
Konrad KowalskiDepartment of Organic Chemistry, Faculty of Chemistry, University of Lodz, Poland.
Yu ChenDepartment of Molecular Medicine, University of South Florida College of Medicine, Tampa, FL, USA.
University of South Florida · USArgonne National Laboratory · USFlorida College · USInstitute of Organic Chemistry · PLUniversity of Łódź · PL

Funding

Evolution and inhibition of beta-lactamase activity in antibiotic resistanceR01AI103158 · NIAID · UNIVERSITY OF SOUTH FLORIDA · PI CHEN, YU · 2013 to 2017
$2.0M
NIAID NIH HHS R01 AI103158
6 · The paper itself

Abstract

The β-lactam antibiotics inhibit penicillin-binding proteins (PBPs) by forming a stable, covalent, acyl-enzyme complex. During the evolution from PBPs to Class A β-lactamases, the β-lactamases acquired Glu166 to activate a catalytic water and cleave the acyl-enzyme bond. Here we present three product complex crystal structures of CTX-M-14 Class A β-lactamase with a ruthenocene-conjugated penicillin-a 0.85 Å resolution structure of E166A mutant complexed with the penilloate product, a 1.30 Å resolution complex structure of the same mutant with the penicilloate product, and a 1.18 Å resolution complex structure of S70G mutant with a penicilloate product epimer-shedding light on the catalytic mechanisms and product inhibition of PBPs and Class A β-lactamases. The E166A-penilloate complex captured the hydrogen bonding network following the protonation of the leaving group and, for the first time, unambiguously show that the ring nitrogen donates a proton to Ser130, which in turn donates a proton to Lys73. These observations indicate that in the absence of Glu166, the equivalent lysine would be neutral in PBPs and therefore capable of serving as the general base to activate the catalytic serine. Together with previous results, this structure suggests a common proton relay network shared by Class A β-lactamases and PBPs, from the catalytic serine to the lysine, and ultimately to the ring nitrogen. Additionally, the E166A-penicilloate complex reveals previously unseen conformational changes of key catalytic residues during the release of the product, and is the first structure to capture the hydrolyzed product in the presence of an unmutated catalytic serine. DATABASE: Structural data are available in the PDB database under the accession numbers 5TOP, 5TOY, and 5VLE.

Indexed as

Protein ConformationProtonsAmino Acid Substitutionbeta-LactamasesBinding SitesBiocatalysisCrystallography, X-RayEscherichia coliHydrogen BondingModels, MolecularMutant ProteinsOrganometallic CompoundsPenicillanic AcidPenicillin-Binding ProteinsRecombinant Proteinsbeta-lactamase CTX-M-14beta-LactamasesMutant ProteinsOrganometallic CompoundsPenicillanic AcidPenicillin-Binding Proteinspenicilloic acidProtonsRecombinant ProteinsruthenoceneCTX-Mpenicillin-binding proteinpenicilloatepenilloateX-ray crystallography

Identifiers

PMID29095570
PMCPMC5760336
OpenAlexW2767585537

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.